Table 3 Prevalence of pfmdr1 N86Y alleles among the study population
Codon | N86 allele | 86Y allele | N86 + 86Y alleles | Total 86Y allele carriage | P* | ||||
|---|---|---|---|---|---|---|---|---|---|
n | % (95%CI) | n | % (95%CI) | n | % (95%CI) | n | % (95%CI) | ||
Total study population | |||||||||
 ANC-1 (N = 151) | 131 | 86.8 (80.3–91.7) | 5 | 3.3 (1.1–7.6) | 15 | 9.9 (5.7–15.9) | 20 | 13.2 (8.3–19.7) | 0.77 |
 Delivery (N = 116) | 102 | 87.9 (80.6–93.2) | 2 | 1.7 (0.2–6.1) | 12 | 10.3 (5.5–17.4) | 14 | 12.1 (6.8–19.4) |  |
Women infected at ANC-1 and at delivery | |||||||||
 ANC-1 (N = 38) | 35 | 92.1 (78.6–98.3) | 1 | 2.6 (0.1–13.8) | 2 | 5.3 (0.6–17.8) | 3 | 7.9 (1.7–21.4) | 0.25 |
 Delivery (N = 31) | 26 | 83.9 (66.3–94.5) | 0 | 0 | 5 | 16.1 (5.4–33.7) | 5 | 16.1 (5.4–33.7) |  |
Women who received standard IPTp-SP | |||||||||
 ANC-1 (N = 81) | 73 | 90.1 (81.5–95.6) | 1 | 1.2 (0.03–6.7) | 7 | 8.7 (3.6–17.0) | 8 | 9.9 (4.4–18.5) | 0.63 |
 Delivery (N = 56) | 49 | 87.5 (75.9–94.8) | 2 | 3.6 (0.4–12.3) | 5 | 8.9 (3.0–19.6) | 7 | 12.5 (5.2–24.1) |  |
Women who received CSST/IPTp-SP | |||||||||
 ANC-1 (N = 70) | 58 | 82.9 (72.0–90.8) | 4 | 5.7 (1.6–14.0) | 8 | 11.4 (5.1–21.3) | 12 | 17.1 (9.2–28.0) | 0.38 |
 Delivery (N = 60) | 53 | 88.3 (77.4–95.2) | 0 | 0 | 7 | 11.7 (4.8–22.6) | 7 | 11.7 (4.8–22.6) |  |